文献速递其他结缔组织病

自身免疫中的平等权利:干燥综合征是否永远是「继发性」?

Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'?
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本文综述了「原发性」与「继发性」干燥综合征(SjS)命名之争的历史及病理生理、时间、遗传、组织学和临床证据,指出「继发性」SjS研究较少且常被排除在临床试验之外,主张进一步研究、更改术语并采用更严格的分类。

要点

  • 「继发性」SjS命名可能导致研究不足和临床试验排除。
  • 支持重新审视术语并采用更严格分类。
  • 呼吁为SjS及其他系统性自身免疫病开展更多试验。

核心结论

  • 「原发性」与「继发性」干燥综合征的命名可能已过时,应进一步研究、更改术语并严格分类。

研究设计与样本

  • 综述,回顾「继发性」SjS概念的历史及病理生理、时间、遗传、组织学和临床数据。

主要发现

  • 「继发性」SjS研究较少且常被排除在临床试验之外,术语存在未预期的后果。

临床怎么用

  • 临床应认识到「继发性」SjS患者可能因命名而面临研究不足和试验排除,需更严格分类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sjögren's syndrome (SjS) accompanied by other systemic autoimmune rheumatic connective tissue diseases has historically been termed 'secondary' in contrast to 'primary' SjS as a standalone entity. However, it is a matter of a long-standing debate whether the prefixes 'primary' and 'secondary', including a temporal component, are obsolete in the terminology of SjS. We review the history and the pathophysiological, chronological, genetic, histological and clinical data underlying the concept of 'secondary' SjS. There are important unintended consequences of the nomenclature; notably 'secondary' SjS has been much less researched and is often excluded from clinical trials. We argue for further research, a change in terminology and more stringent classification. Further we highlight possible opportunities for trials in SjS and other systemic autoimmune diseases that might contribute to an advance in care for all patients with SjS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kollert F, Fisher BA. Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'? Rheumatology (Oxford). 2020. PMID: 32025734. doi:10.1093/rheumatology/keaa009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。